These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8809277)

  • 41. FDA actions against misleading or unsubstantiated economic and quality-of-life promotional claims: an analysis of warning letters and notices of violation.
    Stewart KA; Neumann PJ
    Value Health; 2002; 5(5):390-7. PubMed ID: 12201856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implied Claims in Drug Advertising: A Review of Recent Literature and Regulatory Actions.
    Aikin KJ; Boudewyns V; Betts KR; Giombi KC; Paquin RS; Brewington M; Malik R
    Health Commun; 2024 Apr; 39(4):652-665. PubMed ID: 36825849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An examination of structure-function claims in dietary supplement advertising in the U.S.: 2003-2009.
    Avery RJ; Eisenberg MD; Cantor JH
    Prev Med; 2017 Apr; 97():86-92. PubMed ID: 28115209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study.
    Diep D; Mosleh-Shirazi A; Lexchin J
    BMJ Open; 2020 Jul; 10(7):e034993. PubMed ID: 32690502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmaceutical advertisements in medical journals received in a medical clinic: are we having "too much of a good thing"?
    Lohiya S
    J Natl Med Assoc; 2005 May; 97(5):718-20. PubMed ID: 15926650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct-to-consumer advertising for urological pharmaceuticals: a cross-sectional analysis of print media.
    Folsom C; Fesperman SF; Tojuola B; Sultan S; Dahm P
    Urology; 2010 May; 75(5):1029-33. PubMed ID: 20080293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Now you see it. Now you don't: fair balance and adequate provision in advertisements for drugs before and after the switch from prescription to over-the-counter.
    Faerber AE; Kreling DH
    Health Commun; 2012; 27(1):66-74. PubMed ID: 21745037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
    Findlay SD
    Pharmacoeconomics; 2001; 19(2):109-19. PubMed ID: 11284378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.
    Cooper RJ; Schriger DL
    CMAJ; 2005 Feb; 172(4):487-91. PubMed ID: 15710940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leading-Brand Advertisement of Quitting Smoking Benefits for E-Cigarettes.
    Ramamurthi D; Gall PA; Ayoub N; Jackler RK
    Am J Public Health; 2016 Nov; 106(11):2057-2063. PubMed ID: 27631743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Living in the "land of no"? Consumer perceptions of healthy lifestyle portrayals in direct-to-consumer advertisements of prescription drugs.
    Frosch DL; May SG; Tietbohl C; Pagán JA
    Soc Sci Med; 2011 Oct; 73(7):995-1002. PubMed ID: 21843911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FDA enlists doctors to help spot misleading drug advertisements.
    Tanne JH
    BMJ; 2010 May; 340():c2594. PubMed ID: 20472679
    [No Abstract]   [Full Text] [Related]  

  • 53. Quality of pharmaceutical advertising and gender bias in medical journals (1998-2008): a review of the scientific literature.
    Cambronero Saiz B; Ruiz Cantero MT; Papí Gálvez N
    Gac Sanit; 2012; 26(5):469-76. PubMed ID: 22265644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs.
    Applequist J; Ball JG
    Ann Fam Med; 2018 May; 16(3):211-216. PubMed ID: 29760024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An analysis of 6 decades of hygiene-related advertising: 1940-2000.
    Aiello AE; Larson EL
    Am J Infect Control; 2001 Dec; 29(6):383-8. PubMed ID: 11743485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are advertisements in dental journals supported by an appropriate evidence-base?
    Chestnutt IG; Hardy R
    J Evid Based Dent Pract; 2013 Sep; 13(3):78-83. PubMed ID: 24010998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are the claims made in orthopaedic print advertisements valid?
    Davidson DJ; Rankin KS; Jensen CD; Moverley R; Reed MR; Sprowson AP
    Int Orthop; 2014 May; 38(5):1067-72. PubMed ID: 24162156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The attitudes of consumers toward direct advertising of prescription drugs.
    Morris LA; Brinberg D; Klimberg R; Rivera C; Millstein LG
    Public Health Rep; 1986; 101(1):82-9. PubMed ID: 3080797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct-to-consumer prescription drug advertising, 1989-1998. A content analysis of conditions, targets, inducements, and appeals.
    Bell RA; Kravitz RL; Wilkes MS
    J Fam Pract; 2000 Apr; 49(4):329-35. PubMed ID: 10778839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perpetuating stigma? Differences between advertisements for psychiatric and non-psychiatric medication in two professional journals.
    Foster JL
    J Ment Health; 2010 Feb; 19(1):26-33. PubMed ID: 20380495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.